The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients
It is assumed that SARS-CoV-2- and COVID-19-associated autoimmune processes may affect the outcomes of assisted reproductive technology (ART) cycles. This observational prospective study included 240 infertile patients: 105 patients had no history of COVID-19 (group 1) and 135 patients had experienc...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/13/4370 |
_version_ | 1797591396751769600 |
---|---|
author | Nataliya V. Dolgushina Irina V. Menzhinskaya Daria M. Ermakova Natalia A. Frankevich Valentina V. Vtorushina Gennady T. Sukhikh |
author_facet | Nataliya V. Dolgushina Irina V. Menzhinskaya Daria M. Ermakova Natalia A. Frankevich Valentina V. Vtorushina Gennady T. Sukhikh |
author_sort | Nataliya V. Dolgushina |
collection | DOAJ |
description | It is assumed that SARS-CoV-2- and COVID-19-associated autoimmune processes may affect the outcomes of assisted reproductive technology (ART) cycles. This observational prospective study included 240 infertile patients: 105 patients had no history of COVID-19 (group 1) and 135 patients had experienced COVID-19 (group 2) in a mild (n = 85) or moderate (n = 50) form less than 12 months prior to oocyte retrieval. Using ELISAs, the profiles of their serum autoantibodies were determined, including antiphospholipid antibodies and antibodies to nuclear and thyroid antigens. The parameters of oogenesis and embryogenesis, as well as the pregnancy and childbirth rates, did not differ between groups 1 and 2, and also between the subgroups with different severities of COVID-19. However, when oocyte retrieval was performed less than 180 days after COVID-19, a higher proportion of poor-quality blastocysts was obtained (<i>p</i> = 0.006). A high risk of early miscarriage was found in the patients with moderate COVID-19. In group 2, IgG antibodies to annexin V, phosphatidylethanolamine (PE), and TSHr were detected more often than in group 1 (<i>p</i> = 0.035; <i>p</i> = 0.028; and <i>p</i> = 0.033, respectively), and a weak inverse correlation was revealed between anti-PE IgG and the number of oocytes and zygotes obtained. The results of the study suggest a possible adverse effect of COVID-19 and its associated autoantibodies on the outcomes of fresh oocyte ART cycles and early pregnancy, which depends on the severity of COVID-19 and the time interval after the disease. |
first_indexed | 2024-03-11T01:36:49Z |
format | Article |
id | doaj.art-16a93fe564c54a86a56496a9bf377c59 |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-11T01:36:49Z |
publishDate | 2023-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-16a93fe564c54a86a56496a9bf377c592023-11-18T16:52:55ZengMDPI AGJournal of Clinical Medicine2077-03832023-06-011213437010.3390/jcm12134370The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated PatientsNataliya V. Dolgushina0Irina V. Menzhinskaya1Daria M. Ermakova2Natalia A. Frankevich3Valentina V. Vtorushina4Gennady T. Sukhikh5National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaIt is assumed that SARS-CoV-2- and COVID-19-associated autoimmune processes may affect the outcomes of assisted reproductive technology (ART) cycles. This observational prospective study included 240 infertile patients: 105 patients had no history of COVID-19 (group 1) and 135 patients had experienced COVID-19 (group 2) in a mild (n = 85) or moderate (n = 50) form less than 12 months prior to oocyte retrieval. Using ELISAs, the profiles of their serum autoantibodies were determined, including antiphospholipid antibodies and antibodies to nuclear and thyroid antigens. The parameters of oogenesis and embryogenesis, as well as the pregnancy and childbirth rates, did not differ between groups 1 and 2, and also between the subgroups with different severities of COVID-19. However, when oocyte retrieval was performed less than 180 days after COVID-19, a higher proportion of poor-quality blastocysts was obtained (<i>p</i> = 0.006). A high risk of early miscarriage was found in the patients with moderate COVID-19. In group 2, IgG antibodies to annexin V, phosphatidylethanolamine (PE), and TSHr were detected more often than in group 1 (<i>p</i> = 0.035; <i>p</i> = 0.028; and <i>p</i> = 0.033, respectively), and a weak inverse correlation was revealed between anti-PE IgG and the number of oocytes and zygotes obtained. The results of the study suggest a possible adverse effect of COVID-19 and its associated autoantibodies on the outcomes of fresh oocyte ART cycles and early pregnancy, which depends on the severity of COVID-19 and the time interval after the disease.https://www.mdpi.com/2077-0383/12/13/4370COVID-19SARS-CoV-2autoantibodiesinfertilityassisted reproductive technologyreproductive outcomes |
spellingShingle | Nataliya V. Dolgushina Irina V. Menzhinskaya Daria M. Ermakova Natalia A. Frankevich Valentina V. Vtorushina Gennady T. Sukhikh The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients Journal of Clinical Medicine COVID-19 SARS-CoV-2 autoantibodies infertility assisted reproductive technology reproductive outcomes |
title | The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients |
title_full | The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients |
title_fullStr | The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients |
title_full_unstemmed | The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients |
title_short | The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients |
title_sort | effect of covid 19 severity associated serum autoantibodies and time interval after the disease on the outcomes of fresh oocyte art cycles in non vaccinated patients |
topic | COVID-19 SARS-CoV-2 autoantibodies infertility assisted reproductive technology reproductive outcomes |
url | https://www.mdpi.com/2077-0383/12/13/4370 |
work_keys_str_mv | AT nataliyavdolgushina theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT irinavmenzhinskaya theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT dariamermakova theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT nataliaafrankevich theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT valentinavvtorushina theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT gennadytsukhikh theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT nataliyavdolgushina effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT irinavmenzhinskaya effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT dariamermakova effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT nataliaafrankevich effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT valentinavvtorushina effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients AT gennadytsukhikh effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients |